{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":16,"n_cols":5,"rows_kept":16,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[10,2,10,3],[11,2,11,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910791535503321"]
[null,null,"Autore",null,"Hirsh Jack <1935->"]
[null,null,"Titolo",null,"Guidelines for antithrombotic therapy [[electronic resource] /] / Jack Hirsh"]
[null,null,"Pubbl/distr/stampa",null,"Hamilton, Ont. ; ; London, : B C Decker, 2008"]
[null,null,"ISBN",null,"1-60795-134-7"]
[null,null,"Edizione",null,"[8th ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (184 p.)"]
[null,null,"Soggetti",null,"Thrombosis"]
[{"$nulls":4},"Thrombosis - Prevention"]
[{"$nulls":4},"Thrombolytic therapy"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"\"\"Title and Front matter\"\"; \"\"Contents\"\"; \"\"Introduction\"\"; \"\"1. Grades of Recommendation for Antithrombotic Agents\"\"; \"\"2. Parenteral Anticoagulants\"\"; \"\"3. Pharmacology and Management of Vitamin K Antagonists\"\"; \"\"4. Antiplatelet Drugs\"\"; \"\"5. New Antithrombotic Drugs\"\"; \"\"6. Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment\"\"; \"\"7. Perioperative Management of Antithrombotic Therapy\"\"; \"\"8. Treatment and Prevention of Heparin-Induced Thrombocytopenia: Clinical Features and Diagnosis\"\"; \"\"9. Prevention of Venous Thromboembolism\"\""]
[{"$nulls":4},"\"\"10. Antithrombotic Therapy for Venous Thromboembolic Disease \"\"\"\"11. Antithrombotic Therapy in Atrial Fibrillation\"\"; \"\"12. Valvular and Structural Heart Disease\"\"; \"\"13. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke\"\"; \"\"14. Coronary Heart Disease\"\"; \"\"15. Primary and Secondary Prevention of Chronic Coronary Artery Disease\"\"; \"\"16. Antithrombotic Therapy in Peripheral Arterial Occlusive Disease \"\"; \"\"17. Venous  Thromboembolism, Thrombophilia, and Pregnancy\"\"; \"\"18. Antithrombotic Therapy in Neonates and Children\"\"; \"\"Index\"\""]